TDP-REGv2 Cryptic PE-Max
(Plasmid
#216163)
-
PurposeExpression of prime editing vector PEMax (Plasmid #174820) but only in cells with TDP-43 loss of function
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 216163 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepCMV
-
Vector typeMammalian Expression, CRISPR
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Growth instructionsMUST use stable bacterial line to avoid recombination of UG-rich region (e.g. Stbl3, NEB Stable)
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namePEMax for prime editing with internal cryptic exon
Resource Information
-
A portion of this plasmid was derived from a plasmid made byDavid Liu (pCMV-PEmax ; Addgene plasmid # 174820 ; http://n2t.net/addgene:174820 ; RRID:Addgene_174820). The TDP-REG cryptic exon was inserted into this vector using Gibson assembly.
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please visit https://doi.org/10.1101/2023.11.15.565967 for bioRxiv preprint.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
TDP-REGv2 Cryptic PE-Max was a gift from Pietro Fratta (Addgene plasmid # 216163 ; http://n2t.net/addgene:216163 ; RRID:Addgene_216163) -
For your References section:
Creation of de novo cryptic splicing for ALS/FTD precision medicine. Wilkins OG, Chien MZYJ, Wlaschin JJ, Pisliakova M, Thompson D, Digby H, Simkin RL, Diaz JA, Mehta PR, Keuss MJ, Zanovello M, Brown AL, Harley P, Darbey A, Karda R, Fisher EMC, Cunningham TJ, Le Pichon CE, Ule J, Fratta P. bioRxiv. 2023 Nov 15:2023.11.15.565967. doi: 10.1101/2023.11.15.565967. Preprint. 10.1101/2023.11.15.565967 PubMed 38014203